Wilken, O’Shea TalkAcquisition of HS Pharmaceuticals And What It Means For The Future Of XCRT (via SmallCapVoice)
3 min readJun 24, 2022
May 2022 Interview between HS Pharmaceuticals, Xcelerate, Inc. (OTC: XCRT) and Stuart Smith of SmallCapVoice.com
CEO Mike of O’Shea of Xcelerate, Inc., a development stage startup focused on the development of cutting-edge medtech applications, met with SmallCapVoice.com to…